Evaluate Reactogenicity & Immunogenicity of an Influenza Pandemic Candidate Vaccine (GSK1562902A) in Primed Adults
Clinical trial NCT00506350 · COMPLETED
Trial details
- NCT number
- NCT00506350
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2009-10-12
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.